Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anja Weiß

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Ethnicity & Health|July 10, 2015
Understanding physicians' professional knowledge and practice in research on skilled migrationAnja Weiß
Rheumatology (Oxford, England)|August 16, 2013
Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysisJohanna Callhoff, Anja Weiß, Angela Zink, et al.
Annals of the Rheumatic Diseases|April 11, 2014
Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysisJohanna Callhoff, Joachim Sieper, Anja Weiß, et al.
Arthritis Research & Therapy|January 31, 2014
Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockersAnja Weiß, In-Ho Song, Hildrun Haibel, et al.
RMD Open|April 14, 2017
Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPICAnja Weiß, Kirsten Minden, Joachim Listing, et al.
EULAR Rheumatology Open|June 29, 2026
Which are the clinical characteristics that lead to the decision of primary or secondary usage of TNFi or IL-17i in patients with axial spondyloarthritis?: Real-world evidence from the RABBIT-SpA cohortAnne C Regierer, Anja Weiß, Thomas Marycz, et al.
RMD Open|July 23, 2024
No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registryAnne Constanze Regierer, David Kiefer, Georg Schett, et al.
Rheumatology (Oxford, England)|December 3, 2025
Frequency of difficult-to-manage and treatment-refractory axial SpA: insights from the German RABBIT-SpA register using recent ASAS definitionsFabian Proft, Stephanie Lembke, Anja Weiß, et al.
RMD Open|March 24, 2026
Severe impairments in work ability among patients with axSpA and PsA: results from the RABBIT-SpA RegisterStephanie Lembke, Uta Kiltz, Anja Weiß, et al.
Arthritis Research & Therapy|October 2, 2025
Real-world sex differences in treatment persistence and reasons for discontinuation in psoriatic arthritis patients: results from the German RABBIT-SpA registerLisa Lindner, Anja Weiß, Andreas Reich, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Ethnicity & Health|July 10, 2015
Understanding physicians' professional knowledge and practice in research on skilled migrationAnja Weiß
Rheumatology (Oxford, England)|August 16, 2013
Impact of biologic therapy on functional status in patients with rheumatoid arthritis--a meta-analysisJohanna Callhoff, Anja Weiß, Angela Zink, et al.
Annals of the Rheumatic Diseases|April 11, 2014
Efficacy of TNFα blockers in patients with ankylosing spondylitis and non-radiographic axial spondyloarthritis: a meta-analysisJohanna Callhoff, Joachim Sieper, Anja Weiß, et al.
Arthritis Research & Therapy|January 31, 2014
Good correlation between changes in objective and subjective signs of inflammation in patients with short- but not long duration of axial spondyloarthritis treated with tumor necrosis factor-blockersAnja Weiß, In-Ho Song, Hildrun Haibel, et al.
RMD Open|April 14, 2017
Course of patients with juvenile spondyloarthritis during 4 years of observation, juvenile part of GESPICAnja Weiß, Kirsten Minden, Joachim Listing, et al.
EULAR Rheumatology Open|June 29, 2026
Which are the clinical characteristics that lead to the decision of primary or secondary usage of TNFi or IL-17i in patients with axial spondyloarthritis?: Real-world evidence from the RABBIT-SpA cohortAnne C Regierer, Anja Weiß, Thomas Marycz, et al.
RMD Open|July 23, 2024
No difference in clinical parameters and drug retention in PsA patients receiving b/tsDMARD monotherapy versus combination with methotrexate: data from the RABBIT-SpA registryAnne Constanze Regierer, David Kiefer, Georg Schett, et al.
Rheumatology (Oxford, England)|December 3, 2025
Frequency of difficult-to-manage and treatment-refractory axial SpA: insights from the German RABBIT-SpA register using recent ASAS definitionsFabian Proft, Stephanie Lembke, Anja Weiß, et al.
RMD Open|March 24, 2026
Severe impairments in work ability among patients with axSpA and PsA: results from the RABBIT-SpA RegisterStephanie Lembke, Uta Kiltz, Anja Weiß, et al.
Arthritis Research & Therapy|October 2, 2025
Real-world sex differences in treatment persistence and reasons for discontinuation in psoriatic arthritis patients: results from the German RABBIT-SpA registerLisa Lindner, Anja Weiß, Andreas Reich, et al.
Pageof 3